The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
Open accessAbstract
The renin–angiotensin system (RAS) plays a critical role in the development of diabetic nephropathy, and blockade of the RAS is currently used for treatment of diabetic nephropathy. One major problem for the current RAS inhibitors is the compensatory renin increase, which reduces the efficacy of RAS inhibition. We have shown that vitamin D exerts renoprotective actions by transcriptionally suppressing renin. Here we demonstrated that combination therapy with an AT1 receptor blocker and a vitamin D analog markedly ameliorated renal injury in the streptozotocin (STZ)-induced diabetes model due to the blockade of the compensatory renin rise by the vitamin D analog, leading to more effective RAS inhibition. STZ-treated diabetic DBA/2J mice developed progressive albuminuria and glomerulosclerosis within 13 weeks, accompanied by increased intrarenal production of angiotensin (Ang) II, fibronection, TGF-β, and MCP-1 and decreased expression of slit diaphragm proteins. Treatment of the diabetic mice with losartan or paricalcitol (19-nor-1,25-dihydroxyvitamin D 2 , an activated vitamin D analog) alone moderately ameliorated kidney injury; however, combined treatment with losartan and paricalcitol completely prevented albuminuria, restored glomerular filtration barrier structure, and markedly reduced glomerulosclerosis. The combined treatment suppressed the induction of fibronection, TGF-β, and MCP-1 and reversed the decline of slit diaphragm proteins nephrin, Neph-1, ZO-1, and α-actinin-4. These were accompanied by blockade of intrarenal renin and Ang II accumulation induced by hyperglycemia and losartan. These data demonstrate that inhibition of the RAS with combination of vitamin D analogs and RAS inhibitors effectively prevents renal injury in diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Self-citationLewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Non-Transgenic Mouse Models of Kidney Disease
Rabe, M., & Schaefer, F. (2016) · Nephron · doi:10.1159/000445171 · Cited by 1,922
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839
MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS
Viberti, G. C., Jarrett, R. J., Mahmud, U., Hill, R. D., Argyropoulos, A., & Keen, H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92450-3 · Cited by 1,663
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625
Self-citationPredicting Diabetic Nephropathy in Insulin-Dependent Patients
Mogensen, C. E., & Christensen, C. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407123110204 · Cited by 1,569
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir, L., Giller, T., & Sraer, J.-D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214276 · Cited by 1,137
Kagami, S., Border, W. A., Miller, D. E., & Noble, N. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117251 · Cited by 1,076
Mouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 895
Wood, R. J., Tchack, L., & Taparia, S. (2001) · BMC Physiology · doi:10.1186/1472-6793-1-11 · Cited by 849
The podocyte’s response to injury: role in proteinuria and glomerulosclerosis
Shankland, S. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000410 · Cited by 846
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
Ritz, E., Rychlík, I., Locatelli, F., & Halimi, S. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70035-1 · Cited by 806
Paracrine regulation of the renal microcirculation
Navar, L. G., Inscho, E. W., Majid, S. A., Imig, J. D., Harrison-Bernard, L. M., & Mitchell, K. D. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.2.425 · Cited by 741
FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE
Boneu, B., Abbal, M., Plante, J., & Bierme, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92650-1 · Cited by 716
Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure
Li, Y. C., Qiao, G., Uskokovic, M., Xiang, W., Zheng, W., & Kong, J. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.03.004 · Cited by 615
Self-citationMinireview: Overview of the Renin-Angiotensin System—An Endocrine and Paracrine System
Lavoie, J. L., & Sigmund, C. D. (2003) · Endocrinology · doi:10.1210/en.2003-0150 · Cited by 576
Xiang, W., Kong, J., Chen, S., Cao, L.-P., Qiao, G., Zheng, W., Liu, W., Li, X., Gardner, D. G., & Li, Y. C. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00224.2004 · Cited by 570
Self-citationPathogenesis, prevention, and treatment of diabetic nephropathy
Cooper, M. E. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01346-4 · Cited by 560
Yuan, W., Pan, W., Kong, J., Zheng, W., Szeto, F. L., Wong, K. E., Cohen, R., Klopot, A., Zhang, Z., & Li, Y. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705495200 · Cited by 491
Self-citationMouse Models of Diabetic Nephropathy
Breyer, M. D., Bo[Combining Diaeresis]ttinger, E., Brosius, F. C., Coffman, T. M., Harris, R. C., Heilig, C. W., & Sharma, K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080648 · Cited by 467
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
Agarwal, R., Acharya, M., Tian, J., Hippensteel, R. L., Melnick, J. Z., Qiu, P., Williams, L., & Batlle, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00755.x · Cited by 377
Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., & Krolewski, A. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080872 · Cited by 370
Anderson, S., Jung, F. F., & Ingelfinger, J. R. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.4.f477 · Cited by 307
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Zhang, Z., Sun, L., Wang, Y., Ning, G., Minto, A. W., Kong, J., Quigg, R. J., & Li, Y. C. (2008) · Kidney International · doi:10.1038/sj.ki.5002572 · Cited by 305
Self-citationEijkelkamp, W. B. A., Zhang, Z., Remuzzi, G., Parving, H.-H., Cooper, M. E., Keane, W. F., Shahinfar, S., Gleim, G. W., Weir, M. R., Brenner, B. M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050445 · Cited by 302
Self-citationCharacterization of Susceptibility of Inbred Mouse Strains to Diabetic Nephropathy
Qi, Z., Fujita, H., Jin, J., Davis, L. S., Wang, Y., Fogo, A. B., & Breyer, M. D. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2628 · Cited by 297
Andersen, S., Tarnow, L., Rossing, P., Hansen, B. V., & Parving, H.-H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00880.x · Cited by 289
The Paradox of the Low-Renin State in Diabetic Nephropathy
PRICE, D. A., PORTER, L. E., GORDON, M., FISHER, N. D. L., DE'OLIVEIRA, J. M. F., LAFFEL, L. M. B., PASSAN, D. R., WILLIAMS, G. H., & HOLLENBERG, N. K. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10112382 · Cited by 272
Cooper, M. E., Boner, G., Cao, Z., Kawachi, H., Bonnet, F., & Allen, T. J. (2001) · Diabetologia · doi:10.1007/s001250100546 · Cited by 249
Roig, E. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1740 · Cited by 249
Azizi, M., Ménard, J., Bissery, A., Guyenne, T.-T., Bura-Rivière, A., Vaidyanathan, S., & Camisasca, R. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000146686.35541.29 · Cited by 234
The intrarenal renin–angiotensin system and diabetic nephropathy
Carey, R. M., & Siragy, H. M. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00111-5 · Cited by 230
Renal Interstitial Fluid Concentrations of Angiotensins I and II in Anesthetized Rats
Nishiyama, A., Seth, D. M., & Navar, L. G. (2002) · Hypertension · doi:10.1161/hy0102.100536 · Cited by 230
Vidotti, D. B., Casarini, D. E., Cristovam, P. C., Leite, C. A., Schor, N., & Boim, M. A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00371.2003 · Cited by 224
Chan, J. C. N., Ko, G. T. C., Leung, D. H. Y., Cheung, R. C. K., Cheung, M. Y. F., So, W.-Y., Swaminathan, R., Nicholls, M. G., Critchley, J. A. J. H., & Cockram, C. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00879.x · Cited by 177
Véniant, M., Ménard, J., Bruneval, P., Morley, S., Gonzales, M. F., & Mullins, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119000 · Cited by 174
Zhang, Z., Yuan, W., Sun, L., Szeto, F. L., Wong, K. E., Li, X., Kong, J., & Li, Y. C. (2007) · Kidney International · doi:10.1038/sj.ki.5002296 · Cited by 173
Self-citationEffects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism
Li, Y. C., Bolt, M. J. G., Cao, L.-P., & Sitrin, M. D. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.3.e558 · Cited by 161
Self-citationNephron Number and Renal Risk in Hypertension and Diabetes
Groβ, M.-L., Amann, K., & Ritz, E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110967 · Cited by 160
Kaneshiro, Y., Ichihara, A., Takemitsu, T. Y., Sakoda, M., Suzuki, F., Nakagawa, T., Hayashi, M., & Inagami, T. (2006) · Kidney International · doi:10.1038/sj.ki.5001627 · Cited by 151
Lewis, E. J., Hunsicker, L. G., & al, W. R. C. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00550-5 · Cited by 151
Mechanism of Increased Angiotensin II Levels in Glomerular Mesangial Cells Cultured in High Glucose
Singh, R., Singh, A. K., Alavi, N., & Leehey, D. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000060804.40201.6e · Cited by 149
Borghi, C., Boschi, S., Ambrosioni, E., Melandri, G., Branzi, A., & Magnani, B. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03901.x · Cited by 140
Functional expression of the renin-angiotensin system in human podocytes
Liebau, M. C., Lang, D., Bohm, J. M., Endlich, N., Bek, M. J., Witherden, I. R., Mathieson, P. W., Saleem, M. A., Pavenstädt, H., & Fischer, K.-G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00475.2004 · Cited by 139
Benigni, A., Tomasoni, S., Gagliardini, E., Zoja, C., Grunkemeyer, J. A., Kalluri, R., & Remuzzi, G. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125941 · Cited by 139
Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat
Zimpelmann, J., Kumar, D., Levine, D. Z., Wehbi, G. J., Imig, J. D., Navar, L. G., & Burns, K. D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00416.x · Cited by 133
Direct Renin Inhibition with Aliskiren in Hypertension and Target Organ Damage
Diaeresisller, D. N. M., & Luft, F. C. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01201005 · Cited by 129
Role of podocyte slit diaphragm as a filtration barrier (Review Article)
Kawachi, H., Miyauchi, N., Suzuki, K., Han, G. D., Orikasa, M., & Shimizu, F. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00583.x · Cited by 121
Activation of the renin–angiotensin system within podocytes in diabetes
Yoo, T., Li, J.-J., Kim, J., Jung, D.-S., Kwak, S.-J., Ryu, D., Choi, H. Y., Kim, J. S., Kim, H. J., Han, S. H., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002195 · Cited by 112
Gilbert, R. E., Krum, H., Wilkinson‐Berka, J. L., & Kelly, D. J. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00979.x · Cited by 104
Amelioration of Diabetic Nephropathy in SPARC-Null Mice
Taneda, S., Pippin, J. W., Sage, E. H., Hudkins, K. L., Takeuchi, Y., Couser, W. G., & Alpers, C. E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000054498.83125.90 · Cited by 103
Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice
Kong, J., & Li, Y. C. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00517.2002 · Cited by 79
Self-citationAnalogs of 1α,25-dihydroxyvitamin D3 as novel inhibitors of renin biosynthesis
Qiao, G., Kong, J., Uskoković, M. R., & Li, Y. C. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.02.008 · Cited by 78
Self-citationTakano, Y., Yamauchi, K., Hiramatsu, N., Kasai, A., Hayakawa, K., Yokouchi, M., Yao, J. Q., & Kitamura, M. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00423.2006 · Cited by 62
Differential Inhibition of Renin mRNA Expression by Paricalcitol and Calcitriol in C57/BL6 Mice
Fryer, R. M., Rakestraw, P. A., Nakane, M., Dixon, D. B., Banfor, P. N., Koch, K. A., Wu-Wong, J. R., & Reinhart, G. A. (2007) · Nephron Physiology · doi:10.1159/000104875 · Cited by 54
Ficociello, L., Perkins, B. A., Silva, K. H., Finkelstein, D. M., Ignatowska-Switalska, H., Gaciong, Z. A., Cupples, L. A., Aschengrau, A., Warram, J. H., & Królewski, A. S. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03691106 · Cited by 54
Renoprotection with vitamin D: Specific for diabetic nephropathy?
Klaus, G. (2007) · Kidney International · doi:10.1038/sj.ki.5002693 · Cited by 30
Inhibition of renin: an updated review of the development of renin inhibitors.
Li, Y. C. (2007) · PubMed · Cited by 29
Self-citation
Cited by
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Inflammation and the pathogenesis of diabetic nephropathy
Wada, J., & Makino, H. (2013) · Clinical Science · doi:10.1042/cs20120198 · Cited by 775
de Zeeuw, D., Agarwal, R., Amdahl, M., Audhya, P., Coyne, D., Garimella, T., Parving, H.-H., Pritchett, Y., Remuzzi, G., Ritz, E., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61032-x · Cited by 695
Diabetic nephropathy – complications and treatment
Lim, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s40172 · Cited by 583
Update of pathophysiology and management of diabetic kidney disease
Lin, Y.-C., Chang, Y.-H., Yang, S.-Y., Wu, K.-D., & Chu, T.-S. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.02.007 · Cited by 562
Metadata
- Authors
- Zhang, Z., Zhang, Y., Ning, G., Deb, D. K., Kong, J., & Li, Y. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-10-14
- Volume
- 105
- Issue
- 41
- Pages
- 15896-15901
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2023320327
- Cited by
- 289
- References
- 63
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.